日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus

针对人类内源性逆转录病毒的 T 细胞受体工程 T 细胞可使肾细胞癌消退

Stefan Barisic #, Elizabeth M Brahmbhatt #, Elena Cherkasova, Timothy T Spear, Ujjawal Savani, Stephanie Pierre, Gina M Scurti, Long Chen, Muna Igboko, Rosa Nadal, Gang Zeng, Gordon Parry, David F Stroncek, Steven Highfill, Annika V Dalheim, Robert Reger, Michael I Nishimura #, Richard W Childs #

Profiling the HER3/PI3K pathway in breast tumors using proximity-directed assays identifies correlations between protein complexes and phosphoproteins

使用邻近定向分析分析乳腺肿瘤中的 HER3/PI3K 通路可确定蛋白质复合物和磷蛋白之间的相关性

Ali Mukherjee, Youssouf Badal, Xuan-Thao Nguyen, Johanna Miller, Ahmed Chenna, Hasan Tahir, Alicia Newton, Gordon Parry, Stephen Williams

Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor Specimens

对 FFPE 乳腺癌肿瘤标本中 HER2 总蛋白和 HER2 同型二聚体进行高定量、灵敏、准确且可重复的测定 (HERmark) 的分析验证

Jeffrey S Larson, Laurie J Goodman, Yuping Tan, Lisa Defazio-Eli, Agnes C Paquet, Jennifer W Cook, Amber Rivera, Kristi Frankson, Jolly Bose, Lili Chen, Judy Cheung, Yining Shi, Sarah Irwin, Linda D B Kiss, Weidong Huang, Shannon Utter, Thomas Sherwood, Michael Bates, Jodi Weidler, Gordon Parry, Joh

In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice

86Y 和 111In-antimindin/RG-1 工程抗体片段在 LNCaP 荷瘤裸鼠体内的生物分布、PET 成像和肿瘤蓄积

Douglas W Schneider, Tara Heitner, Bruno Alicke, David R Light, Kirk McLean, Noboru Satozawa, Gordon Parry, Jeongsoo Yoo, Jason S Lewis, Renate Parry